Correlation Between Equillium and Conduit Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Equillium and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Equillium and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Conduit Pharmaceuticals.

Diversification Opportunities for Equillium and Conduit Pharmaceuticals

0.03

Correlation Coefficient

Equillium  Conduit Pharmaceuticals

Significant diversification

The 3 months correlation between Equillium and Conduit is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Equillium i.e., Equillium and Conduit Pharmaceuticals go up and down completely randomly.

Pair Corralation between Equillium and Conduit Pharmaceuticals

Allowing for the 90-day total investment horizon Equillium is expected to generate 3.93 times less return on investment than Conduit Pharmaceuticals. But when comparing it to its historical volatility, Equillium is 2.58 times less risky than Conduit Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  0.70  in Conduit Pharmaceuticals on December 22, 2024 and sell it today you would earn a total of  0.55  from holding Conduit Pharmaceuticals or generate 78.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	85.25%
Values	Daily Returns

Equillium  vs.  Conduit Pharmaceuticals

Equillium

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Equillium are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Equillium reported solid returns over the last few months and may actually be approaching a breakup point.

Conduit Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Equillium and Conduit Pharmaceuticals

The main advantage of trading using opposite Equillium and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.

The idea behind Equillium and Conduit Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.